SRPT News and Press, Sarepta Therapeutics Inc. From 06/07/24

2024-06-07 09:00:09 ET Kostas Biliouris from BMO Capital issued a price target of $170.00 for SRPT on 2024-06-07 07:23:00. The adjusted price target was set to $170.00. At the time of the announcement, SRPT was trading at $117.44. The overall price target consensus is at...

2024-05-30 08:07:15 ET Sarepta Therapeutics (NASDAQ:SRPT) is set to make a significant move by entering the S&P MidCap 400 index, replacing Shockwave Medical. This change, effective before trading begins on June 3, 2024, follows Johnson & Johnson’s acquisition of Shockwav...

2024-05-30 02:45:27 ET More on Sarepta Therapeutics Sarepta Therapeutics, Inc. (SRPT) Q1 2024 Earnings Call Transcript Sarepta Therapeutics: Growth Trajectory Alters Trading Strategy Sarepta Therapeutics: Another 'Hold' Call Ahead Of Some Key Catalysts RBC Ca...

2024-05-29 18:02:29 ET More on Markets A Tale Of Two Indices 2024 Election: What We Think For Markets 'True' Inflation Is Higher Than The 'Official' Numbers Dow sheds more than 400 points, Nasdaq retreats further from 17K, S&P declines U.S. equiti...

Sarepta Therapeutics Set to Join S&P MidCap 400 Sarepta Therapeutics Set to Join S&P MidCap 400 PR Newswire NEW YORK , May 29, 2024 /PRNewswire/ -- Sarepta Therapeutics Inc. (NASD: SRPT) will replace Shockwave Medical Inc. (NASD: SWAV) in the S&P ...

2024-05-28 13:33:15 ET More on Sarepta Therapeutics Sarepta Therapeutics, Inc. (SRPT) Q1 2024 Earnings Call Transcript Sarepta Therapeutics: Growth Trajectory Alters Trading Strategy Sarepta Therapeutics: Another 'Hold' Call Ahead Of Some Key Catalysts Sarept...

2024-05-27 22:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-23 07:10:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the interest cuts coming up, it’s an ideal time to consider loading up on the top biotech stocks . These stocks continue to dazzle with game-changing medical breakthroughs and e...

2024-05-20 16:00:06 ET Brian Abrahams from RBC Capital issued a price target of $157.00 for SRPT on 2024-05-20 14:43:00. The adjusted price target was set to $157.00. At the time of the announcement, SRPT was trading at $130.7. The overall price target consensus is at $1...

2024-05-20 13:58:20 ET Summary PepGen's stock has experienced extreme volatility, with an 80% drop, a 370% rebound, and subsequent decline in 14 months. The rebound was driven by news that Sarepta's DMD exon 51 candidate had lower skipping output than PepGen's PGN-EDO51. PepGe...